Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy

被引：0
|
作者：
Theodoros Michelakos
Yurie Sekigami
Filippos Kontos
Carlos Fernández-del Castillo
Motaz Qadan
Vikram Deshpande
David T. Ting
Jeffrey W. Clark
Colin D. Weekes
Aparna Parikh
David P. Ryan
Jennifer Y. Wo
Theodore S. Hong
Jill N. Allen
Onofrio Catalano
Andrew L. Warshaw
Keith D. Lillemoe
Cristina R. Ferrone
机构：
[1] Harvard Medical School,Department of Surgery, Massachusetts General Hospital
[2] Harvard Medical School,Department of Pathology, Massachusetts General Hospital
[3] Harvard Medical School,Massachusetts General Hospital Cancer Center, Massachusetts General Hospital
[4] Harvard Medical School,Department of Hematology/Oncology, Massachusetts General Hospital
[5] Harvard Medical School,Department of Radiation Oncology, Massachusetts General Hospital
[6] Harvard Medical School,Department of Radiology, Massachusetts General Hospital
来源：
Journal of Gastrointestinal Surgery | 2021年 / 25卷
关键词：
Pancreatic ductal adenocarcinoma; Total neoadjuvant therapy; FOLFIRINOX; Conditional survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2859 / 2870
页数：11
相关论文
共 50 条
  • [21] The Impact of Sampling on Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Taherian, Mehran
    Katz, Matthew
    Prakash, Laura
    Tong, Yi Tat
    Lai, Zongshan
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Ikoma, Naruhiko
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S1529 - S1530
  • [22] Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Shannon, Alexander H.
    Cloyd, Jordan M.
    [J]. MINERVA SURGERY, 2024,
  • [23] Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
    McIntyre, Caitlin A.
    Lawrence, Sharon A.
    Richards, Allison L.
    Chou, Joanne F.
    Wong, Winston
    Capanu, Marinela
    Berger, Michael F.
    Donoghue, Mark T. A.
    Yu, Kenneth H.
    Varghese, Anna M.
    Kelsen, David P.
    Park, Wungki
    Balachandran, Vinod P.
    Kingham, T. Peter
    D'Angelica, Michael, I
    Drebin, Jeffrey A.
    Jarnagin, William R.
    Iacobuzio-Donahue, Christine A.
    Allen, Peter J.
    O'Reilly, Eileen M.
    [J]. CANCER, 2020, 126 (17) : 3939 - 3949
  • [24] The effect of antibiotic use on survival of patients with resected pancreatic ductal adenocarcinoma.
    Hasanov, Merve
    Mohindroo, Chirayu
    Rogers, Jane
    Prakash, Laura
    Overman, Michael J.
    Varadhachary, Gauri Rajani
    Wolff, Robert A.
    Javle, Milind M.
    Fogelman, David R.
    Pant, Shubham
    Katz, Matthew H. G.
    Kim, Michael Paul
    Tzeng, Ching-Wei David
    McAllister, Florencia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Impact of Acute Inflammation on the Survival Outcomes of Patients with Resected Pancreatic Ductal Adenocarcinoma
    Saad, Mohamed Rabie
    Han, Ho-Seong
    Yoon, Yoo-Seok
    Cho, Jai Young
    Lee, Jun Suh
    Shehta, Ahmed
    [J]. DIGESTIVE SURGERY, 2021, 38 (5-6) : 343 - 351
  • [26] Outcomes of Margin Status on Survival in Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Therapy
    Swami, Ashish
    Varshney, Vaibhav Kumar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (06) : 1022 - 1023
  • [27] Obstructive sleep apnea predicts pathologic response to neoadjuvant therapy in resected pancreatic ductal adenocarcinoma
    Shoucair, Sami
    Pu, Ning
    Habib, Joseph R.
    Thompson, Elizabeth
    Shubert, Christopher
    Burkhart, Richard A.
    Burns, William R.
    He, Jin
    Lafaro, Kelly J.
    Yu, Jun
    [J]. MEDCOMM, 2022, 3 (04):
  • [28] Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma
    Vilalta-Lacarra, Anna
    Aldaz, Azucena
    Sala-Elarre, Pablo
    Urrizola, Amaia
    Chopitea, Ana
    Arbea, Leire
    Rotellar, Fernando
    Pardo, Fernando
    Marti-Cruchaga, Pablo
    Zozaya, Gabriel
    Subtil, Jose Carlos
    Rodriguez-Rodriguez, Javier
    Ponz-Sarvise, Mariano
    [J]. PANCREATOLOGY, 2023, 23 (04) : 411 - 419
  • [29] Degree of Resectability Does Not Predict Survival Among Pancreatic Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy and Surgical Resection
    Kontos, F.
    Sekigami, Y.
    Michelakos, T.
    Fernandez del-Castillo, C.
    Qadan, M.
    Lillemoe, K. D.
    Ferrone, C. R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S119 - S120
  • [30] Measured Residual Tumor Cellularity Correlates with Survival in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma
    Rowan, Daniel
    Logunova, Valentina
    Oshima, Kiyoko
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 451A - 451A
12345